ImmuCell Corp

NAS:ICCC (USA)  
$ 5.45 +0.1657 (+3.14%) 10:13 AM EST
At Loss
P/B:
1.62
Market Cap:
$ 42.21M
Enterprise V:
$ 55.62M
Volume:
236.00
Avg Vol (2M):
8.20K
Also Trade In:
Volume:
236.00
At Loss
Avg Vol (2M):
8.20K

Business Description

Description
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The firm has developed products that provide immediate immunity to newborn dairy and beef cattle and is developing product line extensions of its existing products that address mastitis. Its lead product, First Defense, is manufactured to prevent scours in newborn calves. It has two segments Scours and Mastitis. The company generates the majority of its revenue from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.12
Equity-to-Asset 0.58
Debt-to-Equity 0.64
Debt-to-EBITDA -5.14
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.15
Distress
Grey
Safe
Beneish M-Score -1.92
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 68.02
9-Day RSI 60.05
14-Day RSI 56.87
6-1 Month Momentum % 15.79
12-1 Month Momentum % -8.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.59
Quick Ratio 1.38
Cash Ratio 0.6
Days Inventory 187.66
Days Sales Outstanding 39.96
Days Payable 23.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.4
Shareholder Yield % -6.52

Financials (Next Earnings Date:2024-05-10 Est.)

ICCC's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ICCC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ImmuCell Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 16.288
EPS (TTM) ($) -0.81
Beta 0.19
Volatility % 34
14-Day RSI 56.87
14-Day ATR ($) 0.223677
20-Day SMA ($) 5.135435
12-1 Month Momentum % -8.97
52-Week Range ($) 4.26 - 6.16
Shares Outstanding (Mil) 7.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ImmuCell Corp Filings

Filing Date Document Date Form
No Filing Data

ImmuCell Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

ImmuCell Corp Frequently Asked Questions

What is ImmuCell Corp(ICCC)'s stock price today?
The current price of ICCC is $5.45. The 52 week high of ICCC is $6.16 and 52 week low is $4.26.
When is next earnings date of ImmuCell Corp(ICCC)?
The next earnings date of ImmuCell Corp(ICCC) is 2024-05-10 Est..
Does ImmuCell Corp(ICCC) pay dividends? If so, how much?
ImmuCell Corp(ICCC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1